Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

Key Points Disease-free survival is higher with myeloablative regimens for patients in their third to fifth decade. Beyond the fifth decade, low-dose total body irradiation regimens offset mortality associated with transplant procedure.